VJHemOnc is an official media partner of the NYC-Miami Myeloma MRD 2020 Virtual Meeting, organized by the MMRF & Memorial Sloan Kettering Cancer Center, taking place on the 8th of October 2020.
This meeting will bring together leading experts in multiple myeloma who will discuss the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraging interactive discussion.
Explore the exciting program below and don’t forget to register your place before the 8th of October!
Thursday 8th October 2020 (All times are EST)
09:00 – 9:10 AM Welcome and Introductions
09:10 – 9:30 AM MRD in 2020: BMCTN consensus document Luciano Costa, MD, University of Alabama at Birmingham
9:30 – 9:50 AM New trials with MRD focus: GRIFFIN, FORTE, ENDURANCE, MASTER, MANHATTAN Benjamin Derman, MD, University of Chicago
9:50 – 10:10 AM New MRD technologies and future regulatory paths Dickran Kazandjian, MD, NCI and FDA
Session 1: Should sustained MRD negativity be used to stop the treatment? 10:10 – 10:20 AM YES: Nina Shah, UCSF and MMRC Steering Committee 10:20 – 10:30 AM NO: Ajai Chari, MD, Icahn School of Medicine at Mount Sinai and MMRC Steering Committee Session 2: Should MRD+ be used to re-initiate the treatment? 10:30 – 10:40 AM YES: Elisabet Manasanch, MD Anderson 10:40 – 10:50 AM NO: Amrita Krishnan, MD, City of Hope and MMRC Steering Committee
Session 3: Should MRD be used to guide delayed ASCT? 10:40 – 10:50 AM Continue with transplant: Noa Biran, MD, John Theurer Cancer Center 10:30 – 11:00 AM Hold off transplant: Paul Richardson, MD, DFCI
11:00 – 11:25 AM
MRD future directions Moderator: Daniel Auclair, PhD, MMRF
Ola Landgren, MD, PhD
Dickran Kazandjian, MD, NCI, FDA
Ajai Chari, MD, Icahn School of Medicine at Mount Sinai and MMRC Steering Committee
Suzanne Lentzsch, MD, PhD, Columbia University Irving Medical Center
James Hoffman, University of Miami/Sylvester Comprehensive Cancer Center
Sundar Jagannath, MD, Mount Sinai
Noa Biran, MD, John Theurer Cancer Center
Summary and Adjournment 11:25 – 11:30 AM C. Ola Landgren, MD, Memorial Sloan Kettering Cancer Center Daniel Auclair, PhD, MMRF